アルファウイルス受容体MXRA8の脊椎動物特有の結合モード
Ofer Zimmerman1, Maxwell I Zimmerman2, Saravanan Raju2
1Department of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Cell
|October 7, 2023
まとめ
哺乳類のMXRA8とは異なり,鳥類のMXRA8はSindbisやWEEVのようなアルファウイルスに結合する. 新しいキメリック受容体は様々なアルファウイルス感染を中和し,幅広いスペクトルの阻害剤への道を開きます.
科学分野:
- ウイルス学
- 構造生物学
- 免疫学
背景:
- MXRA8はチクングンヤウイルス (CHIKV) と他の哺乳類宿主アルファウイルスに対する既知の受容体である.
- 哺乳類のMXRA8はヒトに感染するアルファウイルスを鳥類の貯蔵体と結合させない.
研究 の 目的:
- アルファウイルス結合における鳥のMXRA8の役割を調査する.
- アルファウイルスとMXRA8の相互作用の構造的基礎を解明する.
- 広範囲のアルファウイルス阻害剤を開発する
主な方法:
- WEEVで複合したアヒルの構造分析
- 鳥類と哺乳類のMXRA8の結合モードの比較
- キメリックMXRA8誘致受容体の生成とテスト
主要な成果:
- 鳥のMXRA8は,哺乳類のMXRA8は,鳥の貯蔵アルファウイルス (例えば,Sindbis,WEEV) の受容体として作用する.
- 哺乳類のMXRA8はCHIKV E1とE2に結合し,鳥類のMXRA8はWEEV E1にのみ結合する.
- 鳥類と哺乳類のMXRA8誘致受容体は,複数のアルファウイルスの中和を in vitroおよび in vivoで実証した.
結論:
- アルファウイルスには,異なる脊椎動物のMXRA8受容体への結合メカニズムがあります.
- これらの異なる結合方式を理解することは 効果的な広範囲の抗ウイルス治療の開発に不可欠です
関連する概念動画
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Transducer Mechanism: G Protein–Coupled Receptors
2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.1K


